Deutsche Bank Ag\ Gossamer Bio, Inc. Transaction History
Deutsche Bank Ag\
- $240 Billion
- Q3 2024
A detailed history of Deutsche Bank Ag\ transactions in Gossamer Bio, Inc. stock. As of the latest transaction made, Deutsche Bank Ag\ holds 2,112,745 shares of GOSS stock, worth $1.48 Million. This represents 0.0% of its overall portfolio holdings.
Number of Shares
2,112,745
Previous 3,807,661
44.51%
Holding current value
$1.48 Million
Previous $3.43 Million
38.97%
% of portfolio
0.0%
Previous 0.0%
Shares
20 transactions
Others Institutions Holding GOSS
# of Institutions
108Shares Held
167MCall Options Held
430KPut Options Held
519K-
Nea Management Company, LLC Timonium, MD18.1MShares$12.7 Million1.37% of portfolio
-
Siren, L.L.C. New York, NY13.3MShares$9.3 Million0.65% of portfolio
-
Vanguard Group Inc Valley Forge, PA11.8MShares$8.23 Million0.0% of portfolio
-
Octagon Capital Advisors LP New York, NY9.19MShares$6.43 Million2.2% of portfolio
-
Arch Venture Management, LLC Chicago, IL8.06MShares$5.64 Million4.79% of portfolio
About Gossamer Bio, Inc.
- Ticker GOSS
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 93,954,000
- Market Cap $65.8M
- Description
- Gossamer Bio, Inc., a clinical-stage biopharmaceutical company, focuses on discovering, acquiring, developing, and commercializing therapeutics in the disease areas of immunology, inflammation, and oncology in the United States. The company is developing GB002, an inhaled, small molecule, platelet-derived growth factor receptor, or PDGFR, colony...